Femasys Inc.
General ticker "FEMY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $15.2M (TTM average)
Femasys Inc. does not follow the US Stock Market performance with the rate: -31.4%.
Estimated limits based on current volatility of 7.5%: low 1.54$, high 1.79$
Factors to consider:
- Total employees count: 89 (+25.4%) as of 2025
- US accounted for 60.8% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Operating losses and profitability, Regulatory and compliance, Sales force recruitment, Liquidity and credit risks, Manufacturing and inventory shortages
- Current price 65.1% below estimated low
- Earnings for 18 months up through Q2 (+1 year) are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.93$, 25.04$]
- 2025-12-31 to 2026-12-31 estimated range: [4.72$, 16.08$]
Financial Metrics affecting the FEMY estimates:
- Negative: with PPE of -1.3 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: negative Operating cash flow
- Negative: negative Net income
- Negative: 0 < Industry inventory ratio change (median), % of 0.08
- Negative: Inventory ratio change, % of 26.80 > 4.02
- Negative: Investing cash flow per share per price, % of -3.44 <= -2.60
- Negative: negative Industry operating income (median)
- Negative: 4.56 < Interest expense per share per price, % of 6.50
- Negative: Industry operating cash flow per share per price (median), % of 1.18 <= 3.66
Short-term FEMY quotes
Long-term FEMY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1.21MM | $1.07MM | $1.63MM |
| Operating Expenses | $12.81MM | $15.58MM | $19.41MM |
| Operating Income | $-11.60MM | $-14.51MM | $-17.79MM |
| Non-Operating Income | $0.21MM | $0.27MM | $-1.02MM |
| Interest Expense | $0.01MM | $0.17MM | $1.60MM |
| R&D Expense | $5.81MM | $7.21MM | $8.22MM |
| Income(Loss) | $-11.39MM | $-14.24MM | $-18.81MM |
| Taxes | $0.01MM | $0.00MM | $0.01MM |
| Net Income(Loss)* | $-11.39MM | $-14.25MM | $-18.82MM |
| Stockholders Equity | $15.24MM | $18.35MM | $2.30MM |
| Inventory | $0.44MM | $0.67MM | $3.05MM |
| Assets | $16.90MM | $27.76MM | $12.45MM |
| Operating Cash Flow | $-10.73MM | $-11.28MM | $-19.44MM |
| Capital expenditure | $0.41MM | $0.14MM | $0.76MM |
| Investing Cash Flow | $-0.41MM | $-0.14MM | $-0.85MM |
| Financing Cash Flow | $-0.68MM | $20.18MM | $2.03MM |
| Earnings Per Share** | $-19.31 | $-18.52 | $-16.91 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.